WO2009078034A3 - Orally disintegrating tablets of ropinirole hydrochloride - Google Patents
Orally disintegrating tablets of ropinirole hydrochloride Download PDFInfo
- Publication number
- WO2009078034A3 WO2009078034A3 PCT/IN2008/000787 IN2008000787W WO2009078034A3 WO 2009078034 A3 WO2009078034 A3 WO 2009078034A3 IN 2008000787 W IN2008000787 W IN 2008000787W WO 2009078034 A3 WO2009078034 A3 WO 2009078034A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ropinirole
- orally disintegrating
- disintegrating tablets
- ropinirole hydrochloride
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/148—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1664—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a solid pharmaceutical composition comprising ropinirole, which dissolves or disintegrates in the oral cavity within about sixty (60) seconds. The present invention further discloses orally disintegrating tablets of ropinirole of optimal mechanical strength comprising taste-masked ropinirole and at least one pharmaceutically acceptable excipient.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2320MU2007 | 2007-11-26 | ||
IN2320/MUM/2007 | 2007-11-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009078034A2 WO2009078034A2 (en) | 2009-06-25 |
WO2009078034A3 true WO2009078034A3 (en) | 2010-01-28 |
Family
ID=40673431
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2008/000787 WO2009078034A2 (en) | 2007-11-26 | 2008-11-26 | Oral disintegrating tablets of ropinirole hydrochloride |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2009078034A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120093738A1 (en) * | 2009-06-11 | 2012-04-19 | Rubicon Research Private Limited | Taste-masked oral formulations of influenza antivirals |
WO2011110939A2 (en) * | 2010-03-11 | 2011-09-15 | Rubicon Research Private Limited | Pharmaceutical compositions of substituted benzhydrylpiperazines |
US9861577B2 (en) | 2010-08-31 | 2018-01-09 | Kyowa Hakko Kirin Co., Ltd. | Orally disintegrating tablet |
JP4803686B2 (en) * | 2010-08-31 | 2011-10-26 | 協和発酵キリン株式会社 | Granules and orally disintegrating tablets containing a bitter-tasting drug |
CA2853117C (en) * | 2011-10-25 | 2018-08-07 | Expermed S.A. | Sublingual pharmaceutical composition containing an antihistamine agent and method for the preparation thereof |
CN105307645A (en) * | 2013-06-03 | 2016-02-03 | 麦克内尔股份公司 | Solid pharmaceutical dosage form for release of at least one active pharmaceutical ingredient in the oral cavity |
WO2015130760A1 (en) | 2014-02-25 | 2015-09-03 | Orbis Biosciences, Inc. | Taste masking drug formulations |
CN107334744B (en) * | 2017-07-24 | 2020-09-04 | 湖南洞庭药业股份有限公司 | Memantine hydrochloride medicine composition and preparation method thereof |
CN118141772B (en) * | 2024-03-08 | 2024-09-10 | 四川鲁徽制药有限责任公司 | Ropinirole Luo Jia hydrochloride sulfonic acid rasagiline compound orally disintegrating controlled release tablet and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004022037A1 (en) * | 2002-09-04 | 2004-03-18 | Ranbaxy Laboratories Limited | Taste masked dosage forms and processes for their preparation |
WO2005018605A2 (en) * | 2003-08-22 | 2005-03-03 | Smithkline Beecham (Cork) Limited | Novel formulation of ropinirole |
WO2007036952A2 (en) * | 2005-07-01 | 2007-04-05 | Rubicon Research Pvt Ltd. | Novel sustained release dosage form |
WO2007113856A2 (en) * | 2006-03-31 | 2007-10-11 | Rubicon Research Private Limited | Directly compressible composite for orally disintegrating tablets |
-
2008
- 2008-11-26 WO PCT/IN2008/000787 patent/WO2009078034A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004022037A1 (en) * | 2002-09-04 | 2004-03-18 | Ranbaxy Laboratories Limited | Taste masked dosage forms and processes for their preparation |
WO2005018605A2 (en) * | 2003-08-22 | 2005-03-03 | Smithkline Beecham (Cork) Limited | Novel formulation of ropinirole |
WO2007036952A2 (en) * | 2005-07-01 | 2007-04-05 | Rubicon Research Pvt Ltd. | Novel sustained release dosage form |
WO2007113856A2 (en) * | 2006-03-31 | 2007-10-11 | Rubicon Research Private Limited | Directly compressible composite for orally disintegrating tablets |
Non-Patent Citations (1)
Title |
---|
RAILKAR A: "Taste masking strategies: A brief review", AMERICAN PHARMACEUTICAL REVIEW 200701 US,, vol. 10, no. 1, 1 January 2007 (2007-01-01), pages 80 - 82, XP002529545 * |
Also Published As
Publication number | Publication date |
---|---|
WO2009078034A2 (en) | 2009-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009084017A3 (en) | Taste-masked orally disintegrating tablets of memantine hydrochloride | |
WO2009078034A3 (en) | Orally disintegrating tablets of ropinirole hydrochloride | |
WO2007113856A3 (en) | Directly compressible composite for orally disintegrating tablets | |
WO2008112124A3 (en) | Orally administrable films | |
WO2009006095A3 (en) | Dual portion lozenge dosage form | |
ZA200704163B (en) | Oral medicament for the modified release of at least one active principle, in a multimicrocapsule form | |
AP2012006231A0 (en) | Capsule formulation of pirfenidone and pharmaceutically acceptable excipients. | |
IL184758A0 (en) | New pharmaceutical compositions useful in the transmucosal administration of drugs | |
ECSP10010052A (en) | GALENIC FORMULATIONS OF ALISQUIRENO AND VALSARTAN | |
WO2004062577A3 (en) | Two or more enteric materials to regulate drug release | |
WO2004069198A3 (en) | Sugar-free oral transmucosal solid dosage forms and uses thereof | |
IL199472A0 (en) | Non-effervescent, orally disintegrating solid pharmaceutical dosage forms, processes for the preparation of the same and uses thereof | |
AU2010308458A8 (en) | Orally transformable tablets | |
WO2007025005A3 (en) | Sustained release formulations of nalbuphine | |
CL2007002766A1 (en) | PHARMACEUTICAL COMPOSITION IN THE FORM OF A CAPSULE THAT INCLUDES A GRANULUM WITH A COMPOSITE DERIVED FROM PYRIMIDIL-AMINO-BENZAMIDE IN INTIMATE MIXTURE WITH AT LEAST ONE PHARMACEUTICALLY ACCEPTABLE EXCIPIENT; METHOD OF PREPARATION OF SUCH COMPOSITION, USEFUL PAR | |
ATE454132T1 (en) | TABLET THAT MELTS QUICKLY IN THE ORAL CAVITY | |
MX2007015480A (en) | Solid dosage formulations of narcotic drugs having improved buccal adsorption. | |
ATE540680T1 (en) | ARIPIPRAZOLE PHARMACEUTICAL COMPOSITIONS | |
WO2011110939A3 (en) | Pharmaceutical compositions of substituted benzhydrylpiperazines | |
SI1800669T1 (en) | Orodispersible pharmaceutical composition for oral, oromucosal or sublingual administration of agomelatine | |
UA92641C2 (en) | Pharmaceutical composition comprising amlodipine and losartan | |
PT2205279E (en) | Pharmaceutical combination of aliskiren and valsartan | |
PL385455A1 (en) | Oral disintegrating pharmaceutical tablet of olanzapine preparations | |
WO2008087323A8 (en) | Galenic form for the transmucosal delivery of paracetamol | |
WO2008039351A3 (en) | Method of manufacturing tablets containing pharmacologically active agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08862812 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08862812 Country of ref document: EP Kind code of ref document: A2 |